Robert Eckert - 18 Aug 2022 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Director
Signature
/s/ Andrea A. Robinson, Attorney-in-Fact for Mr. Eckert
Issuer symbol
AMGN
Transactions as of
18 Aug 2022
Net transactions value
-$1,643,378
Form type
4
Filing time
19 Aug 2022, 18:16:30 UTC
Previous filing
18 Aug 2022
Next filing
23 Nov 2022

Quoteable Key Fact

"Robert Eckert filed Form 4 for AMGEN INC (AMGN) on 19 Aug 2022."

Quick Takeaways

  • This page summarizes Robert Eckert's Form 4 filing for AMGEN INC (AMGN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 19 Aug 2022, 18:16.

What Changed

  • Previous filing in this sequence was filed on 18 Aug 2022.
  • Current net transaction value: -$1,643,378.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Sale $1,643,378 -6,600 -24% $249.00 21,184 18 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is an average price. The prices ranged from $248.73 to $249.19 per share. Full information regarding the number of shares purchased at each separate price within such range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F2 These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .